Chu CM - Search Results

1

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.

Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Lin SM, et al. Among authors: chu cm. Hepatology. 1999 Mar;29(3):971-5. doi: 10.1002/hep.510290312. Hepatology. 1999. PMID: 10051505 Clinical Trial.

2

Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection.

Chu CM, Lin CC, Chen YC, Jeng WJ, Lin SM, Liaw YF. Chu CM, et al. Br J Cancer. 2012 Dec 4;107(12):2010-5. doi: 10.1038/bjc.2012.474. Epub 2012 Oct 18. Br J Cancer. 2012. PMID: 23079574 Free PMC article.

3

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.

Chen YC, Huang SF, Chu CM, Liaw YF. Chen YC, et al. Among authors: chu cm. J Viral Hepat. 2012 Feb;19(2):138-46. doi: 10.1111/j.1365-2893.2011.01450.x. Epub 2011 Mar 14. J Viral Hepat. 2012. PMID: 22239503

4

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.

Chu CM, Liaw YF. Chu CM, et al. J Viral Hepat. 2007 Mar;14(3):147-52. doi: 10.1111/j.1365-2893.2006.00810.x. J Viral Hepat. 2007. PMID: 17305879 Review.

5

Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection?

Chu CM, Lin DY, Liaw YF. Chu CM, et al. Int J Obes (Lond). 2007 May;31(5):871-5. doi: 10.1038/sj.ijo.0803479. Epub 2006 Oct 17. Int J Obes (Lond). 2007. PMID: 17047638 Clinical Trial.

6

Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.

Chu CM, Yeh CT, Sheen IS, Liaw YF. Chu CM, et al. Gut. 2002 Jul;51(1):95-9. doi: 10.1136/gut.51.1.95. Gut. 2002. PMID: 12077099 Free PMC article.

7

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B.

Lin SM, Tai DI, Chien RN, Sheen IS, Chu CM, Liaw YF. Lin SM, et al. Among authors: chu cm. J Viral Hepat. 2004 Jul;11(4):349-57. doi: 10.1111/j.1365-2893.2004.00512.x. J Viral Hepat. 2004. PMID: 15230858 Clinical Trial.

8

Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Liaw YF, Chu CM, Lin DY, Sheen IS, Yang CY, Huang MJ. Liaw YF, et al. Among authors: chu cm. J Med Virol. 1984;13(4):385-91. doi: 10.1002/jmv.1890130410. J Med Virol. 1984. PMID: 6330293

9

Chronic lobular hepatitis: a clinicopathological and prognostic study.

Liaw YF, Chu CM, Chen TJ, Lin DY, Chang-Chien CS, Wu CS. Liaw YF, et al. Among authors: chu cm. Hepatology. 1982 Mar-Apr;2(2):258-62. doi: 10.1002/hep.1840020213. Hepatology. 1982. PMID: 7068120

10

Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.

Liaw YF, Chu CM, Huang MJ, Sheen IS, Yang CY, Lin DY. Liaw YF, et al. Among authors: chu cm. Liver. 1984 Oct;4(5):301-6. doi: 10.1111/j.1600-0676.1984.tb00942.x. Liver. 1984. PMID: 6503634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results